Label: W.SKIN CICA PLUS REPAIR- niacinamide, adenosine cream

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated April 24, 2021

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Niacinamide, Adenosine

  • INACTIVE INGREDIENT

    Water, Butylene Glycol, Caprylic/Capric Triglyceride, Glycerin, Niacinamide, Betaine, Polyglyceryl-3 Methylglucose Distearate, Cetyl Alcohol, Butyrospermum Parkii (Shea) Butter, Glyceryl Stearate, Trehalose, Ammonium Acryloyldimethyltaurate/VP Copolymer, Glyceryl Caprylate, Glyceryl Stearate Citrate, Stearyl Alcohol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Polyisobutene, Chlorphenesin, Myristyl Alcohol, Allantoin, Fragrance, Panthenol, Adenosine, Lauryl Alcohol, Caprylyl/Capryl Glucoside, Sorbitan Oleate, Disodium EDTA, Centella Asiatica Extract, Acacia Senegal Gum, Citric Acid, Peat Water, Hydroxypropyl Methylcellulose, 1,2-Hexanediol, Portulaca Oleracea Extract, Pentylene Glycol, Caprylyl Glycol, Potassium Sorbate

  • PURPOSE

    Help to improve wrinkle and whitening

  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children

  • INDICATIONS & USAGE

    Take an appropriate amount of this product and spread it evenly on the skin.

  • WARNINGS

    If there are any abnormal symptoms or side effects such as red spots, swelling, or itching due to direct sunlight during or after using cosmetics. 2. Avoid using areas with wounds. 3. Precautions for storage and handling. 3.1) Keep out reach of children. 3.2) Keep it out of direct sunlight.

  • DOSAGE & ADMINISTRATION

    for external use only

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    W.SKIN CICA PLUS REPAIR 
    niacinamide, adenosine cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:74997-0010
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE2 g  in 100 mL
    ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.04 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:74997-0010-150 mL in 1 TUBE; Type 0: Not a Combination Product04/25/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other04/25/2021
    Labeler - J&J COMPANY (688995236)
    Registrant - J&J COMPANY (688995236)
    Establishment
    NameAddressID/FEIBusiness Operations
    J&J COMPANY688995236manufacture(74997-0010) , label(74997-0010) , pack(74997-0010)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!